Grant supports research on skin injuries caused by chemical threats, aiming to identify commonalities for medical countermeasure development.
NIH supports basic research on how toxic chemicals injure skin to spur discovery and early development of broad-spectrum medical countermeasures; clinical trials are not allowed.
Funds basic research on the harmful acute and delayed effects of ultra-potent synthetic opioids like fentanyl, including combinations, to develop countermeasures.
NIH funds research on radiation and chemical injuries, injury models, diagnostics, and medical countermeasures for radiological, nuclear, or chemical emergencies; clinical trials are not allowed.
Support basic research to uncover biological/genetic causes of cancer health disparities through innovative studies, methodologies, and data analysis.
NIH supports clinical projects that prepare rare disease therapies or diagnostics for trials through biomarkers, outcome measures, or disease characterization; clinical trials are not allowed.